The Future of Health Data: Where Are We Now and Where Are We Going?
December 9 at 10:30 am PT/1:30 pm ET
New players using new technologies are entering the health care space, acquiring patient data that is more in demand than ever. Health datasets are leveraged to develop tools for diagnosis, monitoring, tracking, and reporting of illnesses. There are myriad new applications, especially in the context of COVID-19. However, reports of data breaches and mismanagement have engendered a lack of trust and an adverse view of many entities that acquire and analyze health data. Use of outdated or poorly gathered non-representative health datasets may raise a risk of disparities in care if the algorithms based on such datasets are applied in real-world settings. When health technology is booming, it is essential to identify the steps required to promote equity in the collection of health-related data. Experts will discuss the effects and implications of current practices and evaluate approaches to ensure that new technologies advance biomedical research through equitable data collection.
Speakers
Andrea Coravos
Co-Founder and CEO, Elektra Labs
James Golden
CEO, WorldQuant Predictive
Alaa Halawa
Co-Head, US Ventures, Mubadala Capital
Richard Merkin
CEO, The Heritage Group; Founder, Richard Merkin Foundation for Stem Cell Research
Don Rucker
National Coordinator for Health Information Technology, US Department of Health and Human Services
Moderator
Jon Fortt
Co-Anchor, Squawk Alley, CNBC
See Also
Data Collection and Use During COVID-19
Cures for Life: Long-Term Follow-Up Data Collection for Cell and Gene Therapies